nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS1—type 1 diabetes mellitus	0.345	0.483	CbGaD
Doxorubicin—NOS3—type 1 diabetes mellitus	0.188	0.263	CbGaD
Doxorubicin—NOS2—type 1 diabetes mellitus	0.181	0.254	CbGaD
Doxorubicin—NOS1—arteriole—type 1 diabetes mellitus	0.00989	0.0994	CbGeAlD
Doxorubicin—NOS3—arteriole—type 1 diabetes mellitus	0.00752	0.0756	CbGeAlD
Doxorubicin—Onycholysis—Ramipril—type 1 diabetes mellitus	0.00584	0.0812	CcSEcCtD
Doxorubicin—NOS3—tunica intima—type 1 diabetes mellitus	0.00533	0.0536	CbGeAlD
Doxorubicin—NOS1—penis—type 1 diabetes mellitus	0.00519	0.0522	CbGeAlD
Doxorubicin—NOS3—penis—type 1 diabetes mellitus	0.00394	0.0397	CbGeAlD
Doxorubicin—Alopecia reversible—Ramipril—type 1 diabetes mellitus	0.00348	0.0484	CcSEcCtD
Doxorubicin—Polyneuropathy—Ramipril—type 1 diabetes mellitus	0.00243	0.0337	CcSEcCtD
Doxorubicin—NOS1—nerve—type 1 diabetes mellitus	0.00238	0.024	CbGeAlD
Doxorubicin—SLC22A16—kidney—type 1 diabetes mellitus	0.00186	0.0187	CbGeAlD
Doxorubicin—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.00164	0.0227	CcSEcCtD
Doxorubicin—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.00161	0.0224	CcSEcCtD
Doxorubicin—AKR1A1—islet of Langerhans—type 1 diabetes mellitus	0.00152	0.0153	CbGeAlD
Doxorubicin—ABCB8—kidney—type 1 diabetes mellitus	0.00145	0.0146	CbGeAlD
Doxorubicin—NDUFS7—islet of Langerhans—type 1 diabetes mellitus	0.00138	0.0139	CbGeAlD
Doxorubicin—AKR1A1—retina—type 1 diabetes mellitus	0.0013	0.0131	CbGeAlD
Doxorubicin—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00126	0.0175	CcSEcCtD
Doxorubicin—AKR1A1—nephron tubule—type 1 diabetes mellitus	0.00123	0.0123	CbGeAlD
Doxorubicin—Parosmia—Ramipril—type 1 diabetes mellitus	0.00122	0.0169	CcSEcCtD
Doxorubicin—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00117	0.0163	CcSEcCtD
Doxorubicin—NDUFS2—islet of Langerhans—type 1 diabetes mellitus	0.00115	0.0115	CbGeAlD
Doxorubicin—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00114	0.0158	CcSEcCtD
Doxorubicin—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00114	0.0158	CcSEcCtD
Doxorubicin—NDUFS3—islet of Langerhans—type 1 diabetes mellitus	0.00113	0.0114	CbGeAlD
Doxorubicin—NDUFS7—nephron tubule—type 1 diabetes mellitus	0.00111	0.0112	CbGeAlD
Doxorubicin—AKR1A1—cardiovascular system—type 1 diabetes mellitus	0.0011	0.0111	CbGeAlD
Doxorubicin—AKR1A1—kidney—type 1 diabetes mellitus	0.00108	0.0108	CbGeAlD
Doxorubicin—DHCR7—islet of Langerhans—type 1 diabetes mellitus	0.00108	0.0108	CbGeAlD
Doxorubicin—AKR1A1—pancreas—type 1 diabetes mellitus	0.00107	0.0108	CbGeAlD
Doxorubicin—NDUFS7—cardiovascular system—type 1 diabetes mellitus	0.001	0.0101	CbGeAlD
Doxorubicin—YWHAG—islet of Langerhans—type 1 diabetes mellitus	0.000987	0.00993	CbGeAlD
Doxorubicin—NOS1—retina—type 1 diabetes mellitus	0.000986	0.00992	CbGeAlD
Doxorubicin—NDUFS2—retina—type 1 diabetes mellitus	0.00098	0.00986	CbGeAlD
Doxorubicin—NDUFS7—kidney—type 1 diabetes mellitus	0.000979	0.00985	CbGeAlD
Doxorubicin—Ageusia—Ramipril—type 1 diabetes mellitus	0.000976	0.0136	CcSEcCtD
Doxorubicin—Liver injury—Ramipril—type 1 diabetes mellitus	0.00094	0.0131	CcSEcCtD
Doxorubicin—AKR1A1—lymphoid tissue—type 1 diabetes mellitus	0.000925	0.00931	CbGeAlD
Doxorubicin—NDUFS2—nephron tubule—type 1 diabetes mellitus	0.000923	0.00929	CbGeAlD
Doxorubicin—DHCR7—retina—type 1 diabetes mellitus	0.00092	0.00925	CbGeAlD
Doxorubicin—NDUFS3—nephron tubule—type 1 diabetes mellitus	0.000912	0.00917	CbGeAlD
Doxorubicin—AURKA—kidney—type 1 diabetes mellitus	0.00091	0.00916	CbGeAlD
Doxorubicin—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.0009	0.0125	CcSEcCtD
Doxorubicin—ABCC6—retina—type 1 diabetes mellitus	0.000896	0.00902	CbGeAlD
Doxorubicin—RALBP1—islet of Langerhans—type 1 diabetes mellitus	0.000892	0.00897	CbGeAlD
Doxorubicin—DHCR7—nephron tubule—type 1 diabetes mellitus	0.000866	0.00871	CbGeAlD
Doxorubicin—Cough increased—Ramipril—type 1 diabetes mellitus	0.000864	0.012	CcSEcCtD
Doxorubicin—Glossitis—Ramipril—type 1 diabetes mellitus	0.000858	0.0119	CcSEcCtD
Doxorubicin—YWHAG—retina—type 1 diabetes mellitus	0.000844	0.00849	CbGeAlD
Doxorubicin—NOS1—cardiovascular system—type 1 diabetes mellitus	0.000834	0.00839	CbGeAlD
Doxorubicin—CBR1—islet of Langerhans—type 1 diabetes mellitus	0.000832	0.00837	CbGeAlD
Doxorubicin—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.000831	0.0115	CcSEcCtD
Doxorubicin—NDUFS2—cardiovascular system—type 1 diabetes mellitus	0.000829	0.00834	CbGeAlD
Doxorubicin—AKR1C3—islet of Langerhans—type 1 diabetes mellitus	0.000822	0.00827	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—type 1 diabetes mellitus	0.000819	0.00824	CbGeAlD
Doxorubicin—NOS1—kidney—type 1 diabetes mellitus	0.000816	0.00821	CbGeAlD
Doxorubicin—NDUFS2—kidney—type 1 diabetes mellitus	0.000811	0.00816	CbGeAlD
Doxorubicin—NDUFS2—pancreas—type 1 diabetes mellitus	0.000806	0.00811	CbGeAlD
Doxorubicin—NDUFS3—kidney—type 1 diabetes mellitus	0.000801	0.00806	CbGeAlD
Doxorubicin—NDUFS3—pancreas—type 1 diabetes mellitus	0.000796	0.00801	CbGeAlD
Doxorubicin—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.000791	0.011	CcSEcCtD
Doxorubicin—AURKA—lymphoid tissue—type 1 diabetes mellitus	0.000782	0.00786	CbGeAlD
Doxorubicin—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.000768	0.0107	CcSEcCtD
Doxorubicin—RALBP1—retina—type 1 diabetes mellitus	0.000762	0.00767	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—type 1 diabetes mellitus	0.000758	0.00763	CbGeAlD
Doxorubicin—DHCR7—pancreas—type 1 diabetes mellitus	0.000756	0.00761	CbGeAlD
Doxorubicin—POR—islet of Langerhans—type 1 diabetes mellitus	0.000751	0.00755	CbGeAlD
Doxorubicin—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.000747	0.0104	CcSEcCtD
Doxorubicin—Neuropathy—Ramipril—type 1 diabetes mellitus	0.000743	0.0103	CcSEcCtD
Doxorubicin—ABCC6—kidney—type 1 diabetes mellitus	0.000742	0.00746	CbGeAlD
Doxorubicin—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.000719	0.00998	CcSEcCtD
Doxorubicin—RALBP1—nephron tubule—type 1 diabetes mellitus	0.000718	0.00722	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—type 1 diabetes mellitus	0.000714	0.00718	CbGeAlD
Doxorubicin—YWHAG—kidney—type 1 diabetes mellitus	0.000699	0.00703	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—type 1 diabetes mellitus	0.000697	0.00701	CbGeAlD
Doxorubicin—YWHAG—pancreas—type 1 diabetes mellitus	0.000694	0.00698	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—type 1 diabetes mellitus	0.000688	0.00692	CbGeAlD
Doxorubicin—XDH—kidney—type 1 diabetes mellitus	0.000681	0.00685	CbGeAlD
Doxorubicin—CBR1—nephron tubule—type 1 diabetes mellitus	0.00067	0.00674	CbGeAlD
Doxorubicin—NQO1—islet of Langerhans—type 1 diabetes mellitus	0.000667	0.00671	CbGeAlD
Doxorubicin—AKR1C3—nephron tubule—type 1 diabetes mellitus	0.000662	0.00666	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—type 1 diabetes mellitus	0.000654	0.00658	CbGeAlD
Doxorubicin—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.000654	0.00908	CcSEcCtD
Doxorubicin—RALBP1—cardiovascular system—type 1 diabetes mellitus	0.000645	0.00649	CbGeAlD
Doxorubicin—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.000642	0.00891	CcSEcCtD
Doxorubicin—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.000639	0.00887	CcSEcCtD
Doxorubicin—NOS3—cardiovascular system—type 1 diabetes mellitus	0.000634	0.00638	CbGeAlD
Doxorubicin—RALBP1—kidney—type 1 diabetes mellitus	0.000631	0.00635	CbGeAlD
Doxorubicin—RALBP1—pancreas—type 1 diabetes mellitus	0.000627	0.0063	CbGeAlD
Doxorubicin—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.000622	0.00864	CcSEcCtD
Doxorubicin—NOS3—kidney—type 1 diabetes mellitus	0.000621	0.00624	CbGeAlD
Doxorubicin—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.000609	0.00845	CcSEcCtD
Doxorubicin—POR—nephron tubule—type 1 diabetes mellitus	0.000604	0.00608	CbGeAlD
Doxorubicin—Renal impairment—Ramipril—type 1 diabetes mellitus	0.000603	0.00838	CcSEcCtD
Doxorubicin—CBR1—cardiovascular system—type 1 diabetes mellitus	0.000602	0.00605	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—type 1 diabetes mellitus	0.0006	0.00604	CbGeAlD
Doxorubicin—Purpura—Ramipril—type 1 diabetes mellitus	0.000596	0.00827	CcSEcCtD
Doxorubicin—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.000593	0.00824	CcSEcCtD
Doxorubicin—CBR1—kidney—type 1 diabetes mellitus	0.000589	0.00592	CbGeAlD
Doxorubicin—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000588	0.00817	CcSEcCtD
Doxorubicin—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.000588	0.00817	CcSEcCtD
Doxorubicin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000586	0.00814	CcSEcCtD
Doxorubicin—AKR1C3—pancreas—type 1 diabetes mellitus	0.000578	0.00581	CbGeAlD
Doxorubicin—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000577	0.00801	CcSEcCtD
Doxorubicin—NQO1—retina—type 1 diabetes mellitus	0.00057	0.00574	CbGeAlD
Doxorubicin—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.000538	0.00747	CcSEcCtD
Doxorubicin—NQO1—nephron tubule—type 1 diabetes mellitus	0.000537	0.0054	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—type 1 diabetes mellitus	0.000533	0.00536	CbGeAlD
Doxorubicin—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00053	0.00736	CcSEcCtD
Doxorubicin—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000524	0.00728	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000524	0.00728	CcSEcCtD
Doxorubicin—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000519	0.00721	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.000517	0.00718	CcSEcCtD
Doxorubicin—Gastritis—Ramipril—type 1 diabetes mellitus	0.000508	0.00706	CcSEcCtD
Doxorubicin—CBR1—lymphoid tissue—type 1 diabetes mellitus	0.000506	0.00509	CbGeAlD
Doxorubicin—Influenza—Ramipril—type 1 diabetes mellitus	0.000496	0.00689	CcSEcCtD
Doxorubicin—Asthma—Ramipril—type 1 diabetes mellitus	0.000496	0.00689	CcSEcCtD
Doxorubicin—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000496	0.00689	CcSEcCtD
Doxorubicin—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000491	0.00682	CcSEcCtD
Doxorubicin—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.000487	0.00676	CcSEcCtD
Doxorubicin—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.000483	0.00671	CcSEcCtD
Doxorubicin—NQO1—cardiovascular system—type 1 diabetes mellitus	0.000482	0.00485	CbGeAlD
Doxorubicin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000477	0.00663	CcSEcCtD
Doxorubicin—NQO1—kidney—type 1 diabetes mellitus	0.000472	0.00475	CbGeAlD
Doxorubicin—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000471	0.00655	CcSEcCtD
Doxorubicin—NQO1—pancreas—type 1 diabetes mellitus	0.000469	0.00472	CbGeAlD
Doxorubicin—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000464	0.00644	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000461	0.00641	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000453	0.00629	CcSEcCtD
Doxorubicin—Weight increased—Ramipril—type 1 diabetes mellitus	0.000452	0.00627	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000439	0.00609	CcSEcCtD
Doxorubicin—Renal failure—Ramipril—type 1 diabetes mellitus	0.000435	0.00604	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000434	0.00602	CcSEcCtD
Doxorubicin—Jaundice—Ramipril—type 1 diabetes mellitus	0.000431	0.00599	CcSEcCtD
Doxorubicin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000431	0.00599	CcSEcCtD
Doxorubicin—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00043	0.00597	CcSEcCtD
Doxorubicin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00043	0.00597	CcSEcCtD
Doxorubicin—Sweating—Ramipril—type 1 diabetes mellitus	0.000424	0.00589	CcSEcCtD
Doxorubicin—ABCC3—kidney—type 1 diabetes mellitus	0.000424	0.00426	CbGeAlD
Doxorubicin—ABCC10—kidney—type 1 diabetes mellitus	0.000421	0.00424	CbGeAlD
Doxorubicin—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000418	0.00581	CcSEcCtD
Doxorubicin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000417	0.0058	CcSEcCtD
Doxorubicin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000415	0.00577	CcSEcCtD
Doxorubicin—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000413	0.00573	CcSEcCtD
Doxorubicin—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000397	0.00552	CcSEcCtD
Doxorubicin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000391	0.00543	CcSEcCtD
Doxorubicin—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00039	0.00542	CcSEcCtD
Doxorubicin—ABCC2—nephron tubule—type 1 diabetes mellitus	0.000385	0.00387	CbGeAlD
Doxorubicin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000383	0.00532	CcSEcCtD
Doxorubicin—CYP1B1—nephron tubule—type 1 diabetes mellitus	0.000377	0.00379	CbGeAlD
Doxorubicin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000376	0.00522	CcSEcCtD
Doxorubicin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00037	0.00514	CcSEcCtD
Doxorubicin—Flushing—Ramipril—type 1 diabetes mellitus	0.000369	0.00512	CcSEcCtD
Doxorubicin—ABCC10—lymphoid tissue—type 1 diabetes mellitus	0.000362	0.00364	CbGeAlD
Doxorubicin—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000359	0.00498	CcSEcCtD
Doxorubicin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000358	0.00497	CcSEcCtD
Doxorubicin—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000355	0.00493	CcSEcCtD
Doxorubicin—Alopecia—Ramipril—type 1 diabetes mellitus	0.000351	0.00487	CcSEcCtD
Doxorubicin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000348	0.00483	CcSEcCtD
Doxorubicin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000346	0.0048	CcSEcCtD
Doxorubicin—Erythema—Ramipril—type 1 diabetes mellitus	0.000346	0.0048	CcSEcCtD
Doxorubicin—Tension—Ramipril—type 1 diabetes mellitus	0.000339	0.00471	CcSEcCtD
Doxorubicin—CYP1B1—cardiovascular system—type 1 diabetes mellitus	0.000339	0.00341	CbGeAlD
Doxorubicin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000339	0.0047	CcSEcCtD
Doxorubicin—ABCC2—kidney—type 1 diabetes mellitus	0.000338	0.0034	CbGeAlD
Doxorubicin—Nervousness—Ramipril—type 1 diabetes mellitus	0.000336	0.00466	CcSEcCtD
Doxorubicin—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000332	0.00462	CcSEcCtD
Doxorubicin—CYP1B1—kidney—type 1 diabetes mellitus	0.000331	0.00333	CbGeAlD
Doxorubicin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000321	0.00446	CcSEcCtD
Doxorubicin—Agitation—Ramipril—type 1 diabetes mellitus	0.000318	0.00441	CcSEcCtD
Doxorubicin—Malaise—Ramipril—type 1 diabetes mellitus	0.000312	0.00433	CcSEcCtD
Doxorubicin—Vertigo—Ramipril—type 1 diabetes mellitus	0.000311	0.00431	CcSEcCtD
Doxorubicin—Syncope—Ramipril—type 1 diabetes mellitus	0.00031	0.00431	CcSEcCtD
Doxorubicin—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00031	0.0043	CcSEcCtD
Doxorubicin—Palpitations—Ramipril—type 1 diabetes mellitus	0.000306	0.00424	CcSEcCtD
Doxorubicin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000304	0.00422	CcSEcCtD
Doxorubicin—Cough—Ramipril—type 1 diabetes mellitus	0.000302	0.00419	CcSEcCtD
Doxorubicin—Convulsion—Ramipril—type 1 diabetes mellitus	0.0003	0.00416	CcSEcCtD
Doxorubicin—Myalgia—Ramipril—type 1 diabetes mellitus	0.000294	0.00409	CcSEcCtD
Doxorubicin—Chest pain—Ramipril—type 1 diabetes mellitus	0.000294	0.00409	CcSEcCtD
Doxorubicin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000294	0.00409	CcSEcCtD
Doxorubicin—Anxiety—Ramipril—type 1 diabetes mellitus	0.000293	0.00407	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000292	0.00406	CcSEcCtD
Doxorubicin—Discomfort—Ramipril—type 1 diabetes mellitus	0.000291	0.00404	CcSEcCtD
Doxorubicin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000288	0.004	CcSEcCtD
Doxorubicin—CYP1B1—lymphoid tissue—type 1 diabetes mellitus	0.000285	0.00286	CbGeAlD
Doxorubicin—Confusional state—Ramipril—type 1 diabetes mellitus	0.000285	0.00395	CcSEcCtD
Doxorubicin—Oedema—Ramipril—type 1 diabetes mellitus	0.000282	0.00392	CcSEcCtD
Doxorubicin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000282	0.00392	CcSEcCtD
Doxorubicin—ABCG2—nephron tubule—type 1 diabetes mellitus	0.000281	0.00282	CbGeAlD
Doxorubicin—Shock—Ramipril—type 1 diabetes mellitus	0.000278	0.00386	CcSEcCtD
Doxorubicin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000277	0.00384	CcSEcCtD
Doxorubicin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000276	0.00384	CcSEcCtD
Doxorubicin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000275	0.00383	CcSEcCtD
Doxorubicin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000274	0.00381	CcSEcCtD
Doxorubicin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000273	0.00379	CcSEcCtD
Doxorubicin—Anorexia—Ramipril—type 1 diabetes mellitus	0.000269	0.00374	CcSEcCtD
Doxorubicin—Hypotension—Ramipril—type 1 diabetes mellitus	0.000264	0.00366	CcSEcCtD
Doxorubicin—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.000259	0.00261	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000257	0.00357	CcSEcCtD
Doxorubicin—Insomnia—Ramipril—type 1 diabetes mellitus	0.000255	0.00354	CcSEcCtD
Doxorubicin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000253	0.00352	CcSEcCtD
Doxorubicin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000252	0.00349	CcSEcCtD
Doxorubicin—Somnolence—Ramipril—type 1 diabetes mellitus	0.000251	0.00348	CcSEcCtD
Doxorubicin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000248	0.00345	CcSEcCtD
Doxorubicin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000245	0.00341	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000244	0.00338	CcSEcCtD
Doxorubicin—Fatigue—Ramipril—type 1 diabetes mellitus	0.000243	0.00338	CcSEcCtD
Doxorubicin—Constipation—Ramipril—type 1 diabetes mellitus	0.000241	0.00335	CcSEcCtD
Doxorubicin—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.000233	0.00234	CbGeAlD
Doxorubicin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000233	0.00323	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000231	0.0032	CcSEcCtD
Doxorubicin—CYP2B6—kidney—type 1 diabetes mellitus	0.000228	0.00229	CbGeAlD
Doxorubicin—Urticaria—Ramipril—type 1 diabetes mellitus	0.000224	0.00311	CcSEcCtD
Doxorubicin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000223	0.0031	CcSEcCtD
Doxorubicin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000223	0.0031	CcSEcCtD
Doxorubicin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000208	0.00289	CcSEcCtD
Doxorubicin—Asthenia—Ramipril—type 1 diabetes mellitus	0.000202	0.00281	CcSEcCtD
Doxorubicin—Pruritus—Ramipril—type 1 diabetes mellitus	0.0002	0.00277	CcSEcCtD
Doxorubicin—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.000196	0.00197	CbGeAlD
Doxorubicin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000193	0.00268	CcSEcCtD
Doxorubicin—Dizziness—Ramipril—type 1 diabetes mellitus	0.000187	0.00259	CcSEcCtD
Doxorubicin—Vomiting—Ramipril—type 1 diabetes mellitus	0.000179	0.00249	CcSEcCtD
Doxorubicin—Rash—Ramipril—type 1 diabetes mellitus	0.000178	0.00247	CcSEcCtD
Doxorubicin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000178	0.00247	CcSEcCtD
Doxorubicin—Headache—Ramipril—type 1 diabetes mellitus	0.000177	0.00246	CcSEcCtD
Doxorubicin—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000172	0.00173	CbGeAlD
Doxorubicin—CYP3A4—kidney—type 1 diabetes mellitus	0.000172	0.00173	CbGeAlD
Doxorubicin—CYP2D6—kidney—type 1 diabetes mellitus	0.000169	0.0017	CbGeAlD
Doxorubicin—Nausea—Ramipril—type 1 diabetes mellitus	0.000168	0.00233	CcSEcCtD
Doxorubicin—ABCB1—retina—type 1 diabetes mellitus	0.000147	0.00148	CbGeAlD
Doxorubicin—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000138	0.00139	CbGeAlD
Doxorubicin—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000124	0.00125	CbGeAlD
Doxorubicin—ABCB1—kidney—type 1 diabetes mellitus	0.000122	0.00122	CbGeAlD
Doxorubicin—ABCB1—pancreas—type 1 diabetes mellitus	0.000121	0.00122	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000105	0.00105	CbGeAlD
Doxorubicin—NOS2—Disease—HLA-A—type 1 diabetes mellitus	1.64e-05	0.000143	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALB—type 1 diabetes mellitus	1.64e-05	0.000143	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.63e-05	0.000142	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.62e-05	0.000141	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.62e-05	0.000141	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ITPR3—type 1 diabetes mellitus	1.61e-05	0.00014	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.61e-05	0.00014	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—HBA1—type 1 diabetes mellitus	1.58e-05	0.000138	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC11A1—type 1 diabetes mellitus	1.58e-05	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB3—type 1 diabetes mellitus	1.58e-05	0.000137	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CAT—type 1 diabetes mellitus	1.58e-05	0.000137	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOC3—type 1 diabetes mellitus	1.57e-05	0.000137	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—NOS3—type 1 diabetes mellitus	1.57e-05	0.000137	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2—type 1 diabetes mellitus	1.56e-05	0.000136	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TYK2—type 1 diabetes mellitus	1.55e-05	0.000135	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CCR5—type 1 diabetes mellitus	1.55e-05	0.000135	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GSTT1—type 1 diabetes mellitus	1.55e-05	0.000135	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOS3—type 1 diabetes mellitus	1.52e-05	0.000133	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—INS—type 1 diabetes mellitus	1.52e-05	0.000133	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CAT—type 1 diabetes mellitus	1.52e-05	0.000132	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—HBA1—type 1 diabetes mellitus	1.52e-05	0.000132	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GCG—type 1 diabetes mellitus	1.52e-05	0.000132	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HLA-A—type 1 diabetes mellitus	1.51e-05	0.000132	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ITPR3—type 1 diabetes mellitus	1.51e-05	0.000131	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOC3—type 1 diabetes mellitus	1.51e-05	0.000131	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.5e-05	0.000131	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HBA2—type 1 diabetes mellitus	1.5e-05	0.00013	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.5e-05	0.00013	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	1.49e-05	0.00013	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GSTT1—type 1 diabetes mellitus	1.48e-05	0.000129	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD86—type 1 diabetes mellitus	1.48e-05	0.000129	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.47e-05	0.000128	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	1.47e-05	0.000128	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	1.46e-05	0.000127	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.45e-05	0.000126	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.45e-05	0.000126	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.42e-05	0.000124	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SST—type 1 diabetes mellitus	1.42e-05	0.000124	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.42e-05	0.000123	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CAT—type 1 diabetes mellitus	1.41e-05	0.000123	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOC3—type 1 diabetes mellitus	1.41e-05	0.000123	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IAPP—type 1 diabetes mellitus	1.41e-05	0.000123	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—G6PC2—type 1 diabetes mellitus	1.41e-05	0.000123	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—type 1 diabetes mellitus	1.4e-05	0.000122	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.4e-05	0.000122	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.4e-05	0.000122	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD80—type 1 diabetes mellitus	1.39e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.37e-05	0.000119	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.36e-05	0.000118	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	1.36e-05	0.000118	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—B2M—type 1 diabetes mellitus	1.35e-05	0.000118	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	1.34e-05	0.000117	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.34e-05	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB3—type 1 diabetes mellitus	1.33e-05	0.000116	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—KCNJ11—type 1 diabetes mellitus	1.32e-05	0.000115	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS2—type 1 diabetes mellitus	1.31e-05	0.000114	CbGpPWpGaD
Doxorubicin—NOS2—Disease—INS—type 1 diabetes mellitus	1.31e-05	0.000114	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CCR5—type 1 diabetes mellitus	1.31e-05	0.000114	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.3e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	1.29e-05	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CAT—type 1 diabetes mellitus	1.28e-05	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HLA-A—type 1 diabetes mellitus	1.28e-05	0.000111	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD80—type 1 diabetes mellitus	1.28e-05	0.000111	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.27e-05	0.000111	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.27e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ITPR3—type 1 diabetes mellitus	1.26e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GCG—type 1 diabetes mellitus	1.23e-05	0.000107	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ITPR3—type 1 diabetes mellitus	1.22e-05	0.000106	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.22e-05	0.000106	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCC8—type 1 diabetes mellitus	1.22e-05	0.000106	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—INS—type 1 diabetes mellitus	1.21e-05	0.000105	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—HBA1—type 1 diabetes mellitus	1.19e-05	0.000104	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.19e-05	0.000103	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.18e-05	0.000103	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOC3—type 1 diabetes mellitus	1.18e-05	0.000103	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GCG—type 1 diabetes mellitus	1.18e-05	0.000103	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TYK2—type 1 diabetes mellitus	1.17e-05	0.000102	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.16e-05	0.000101	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTT1—type 1 diabetes mellitus	1.16e-05	0.000101	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—HBA1—type 1 diabetes mellitus	1.15e-05	0.0001	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NOS3—type 1 diabetes mellitus	1.15e-05	0.0001	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOC3—type 1 diabetes mellitus	1.14e-05	9.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS1—type 1 diabetes mellitus	1.14e-05	9.88e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.13e-05	9.87e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.13e-05	9.86e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTT1—type 1 diabetes mellitus	1.12e-05	9.77e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	1.11e-05	9.68e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOS2—type 1 diabetes mellitus	1.11e-05	9.67e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	1.11e-05	9.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.1e-05	9.61e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—type 1 diabetes mellitus	1.09e-05	9.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.09e-05	9.45e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD80—type 1 diabetes mellitus	1.08e-05	9.38e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TYK2—type 1 diabetes mellitus	1.08e-05	9.37e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.07e-05	9.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.07e-05	9.32e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.07e-05	9.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRKCQ—type 1 diabetes mellitus	1.06e-05	9.25e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—type 1 diabetes mellitus	1.06e-05	9.22e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS3—type 1 diabetes mellitus	1.06e-05	9.2e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	1.05e-05	9.11e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—INS—type 1 diabetes mellitus	1.05e-05	9.11e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CAT—type 1 diabetes mellitus	1.04e-05	9.07e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	1.04e-05	9.07e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	1.04e-05	9.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	1.04e-05	9.05e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.03e-05	9.01e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.03e-05	9.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—VAV1—type 1 diabetes mellitus	1.03e-05	8.99e-05	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.03e-05	8.96e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	1.02e-05	8.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—INS—type 1 diabetes mellitus	1.02e-05	8.86e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.02e-05	8.85e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—INS—type 1 diabetes mellitus	1.01e-05	8.79e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CAT—type 1 diabetes mellitus	9.99e-06	8.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	9.9e-06	8.62e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—type 1 diabetes mellitus	9.89e-06	8.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.82e-06	8.55e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	9.79e-06	8.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—type 1 diabetes mellitus	9.74e-06	8.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—KCNJ11—type 1 diabetes mellitus	9.66e-06	8.41e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—type 1 diabetes mellitus	9.59e-06	8.35e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.53e-06	8.29e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—INS—type 1 diabetes mellitus	9.38e-06	8.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.33e-06	8.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—type 1 diabetes mellitus	9.25e-06	8.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GCG—type 1 diabetes mellitus	9.25e-06	8.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.18e-06	7.99e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NOS3—type 1 diabetes mellitus	9.17e-06	7.99e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TYK2—type 1 diabetes mellitus	9.1e-06	7.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.04e-06	7.87e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	9.01e-06	7.84e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD86—type 1 diabetes mellitus	9e-06	7.84e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	8.95e-06	7.79e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GCG—type 1 diabetes mellitus	8.95e-06	7.79e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD80—type 1 diabetes mellitus	8.93e-06	7.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NOS3—type 1 diabetes mellitus	8.85e-06	7.7e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.66e-06	7.54e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—type 1 diabetes mellitus	8.6e-06	7.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—INS—type 1 diabetes mellitus	8.53e-06	7.42e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	8.49e-06	7.39e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—INS—type 1 diabetes mellitus	8.44e-06	7.35e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NOS3—type 1 diabetes mellitus	8.23e-06	7.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—type 1 diabetes mellitus	8.23e-06	7.16e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—type 1 diabetes mellitus	8.2e-06	7.14e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.16e-06	7.11e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ITPR3—type 1 diabetes mellitus	8.15e-06	7.09e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	8.14e-06	7.08e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB3—type 1 diabetes mellitus	8.12e-06	7.07e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—type 1 diabetes mellitus	7.98e-06	6.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CAT—type 1 diabetes mellitus	7.83e-06	6.82e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—type 1 diabetes mellitus	7.82e-06	6.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HLA-A—type 1 diabetes mellitus	7.78e-06	6.77e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	7.67e-06	6.68e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	7.62e-06	6.64e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—type 1 diabetes mellitus	7.6e-06	6.61e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAT—type 1 diabetes mellitus	7.57e-06	6.59e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	7.56e-06	6.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD80—type 1 diabetes mellitus	7.55e-06	6.57e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.54e-06	6.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—type 1 diabetes mellitus	7.54e-06	6.56e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	7.49e-06	6.52e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—type 1 diabetes mellitus	7.46e-06	6.49e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.4e-06	6.44e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	7.2e-06	6.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—INS—type 1 diabetes mellitus	7.13e-06	6.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	7.12e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—INS—type 1 diabetes mellitus	6.92e-06	6.02e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.9e-06	6e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	6.89e-06	6e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—type 1 diabetes mellitus	6.85e-06	5.96e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	6.81e-06	5.93e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—type 1 diabetes mellitus	6.77e-06	5.89e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	6.71e-06	5.84e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—type 1 diabetes mellitus	6.66e-06	5.79e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—INS—type 1 diabetes mellitus	6.63e-06	5.77e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD80—type 1 diabetes mellitus	6.57e-06	5.72e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	6.4e-06	5.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.37e-06	5.55e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—type 1 diabetes mellitus	6.37e-06	5.55e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—type 1 diabetes mellitus	6.34e-06	5.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.28e-06	5.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—type 1 diabetes mellitus	6.27e-06	5.46e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—INS—type 1 diabetes mellitus	6.21e-06	5.4e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—type 1 diabetes mellitus	6.08e-06	5.29e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NOS3—type 1 diabetes mellitus	6.07e-06	5.28e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	6.01e-06	5.23e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	5.97e-06	5.19e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—type 1 diabetes mellitus	5.82e-06	5.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—type 1 diabetes mellitus	5.79e-06	5.04e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—type 1 diabetes mellitus	5.73e-06	4.99e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	5.66e-06	4.93e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	5.66e-06	4.92e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	5.62e-06	4.89e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	5.55e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TYK2—type 1 diabetes mellitus	5.54e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	5.52e-06	4.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—type 1 diabetes mellitus	5.44e-06	4.74e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	5.33e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.31e-06	4.62e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—type 1 diabetes mellitus	5.3e-06	4.61e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	5.3e-06	4.61e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.28e-06	4.6e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—type 1 diabetes mellitus	5.27e-06	4.58e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	5.2e-06	4.53e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INS—type 1 diabetes mellitus	5.2e-06	4.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	5.05e-06	4.4e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INS—type 1 diabetes mellitus	5.03e-06	4.38e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—type 1 diabetes mellitus	5.01e-06	4.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.84e-06	4.21e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.8e-06	4.18e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—type 1 diabetes mellitus	4.76e-06	4.15e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—type 1 diabetes mellitus	4.61e-06	4.01e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INS—type 1 diabetes mellitus	4.57e-06	3.98e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—type 1 diabetes mellitus	4.56e-06	3.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.46e-06	3.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—type 1 diabetes mellitus	4.45e-06	3.87e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—type 1 diabetes mellitus	4.41e-06	3.84e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	4.4e-06	3.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	4.39e-06	3.82e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	4.19e-06	3.65e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	4.15e-06	3.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.05e-06	3.53e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	4.01e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—type 1 diabetes mellitus	3.88e-06	3.38e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	3.72e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	3.7e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.69e-06	3.21e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—type 1 diabetes mellitus	3.53e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	3.51e-06	3.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	3.49e-06	3.03e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	3.46e-06	3.02e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	3.4e-06	2.96e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	3.35e-06	2.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.12e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	3.07e-06	2.68e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	2.94e-06	2.56e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—type 1 diabetes mellitus	2.71e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	2.71e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INS—type 1 diabetes mellitus	2.47e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.33e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.29e-06	2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.27e-06	1.97e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.17e-06	1.89e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.14e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.04e-06	1.78e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.52e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.4e-06	1.22e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.34e-06	1.16e-05	CbGpPWpGaD
